APC8015, a Therapeutic Vaccine for Prostate Cancer, Targets Prostatic Acid Phosphatase

Cancer Biology and Therapy - United States
doi 10.4161/cbt.4.3.1630
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Radioimmunoassay of Serum Prostatic Acid Phosphatase in Prostatic Cancer.

BMJ
1978English

DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-Term T-Cell Responses in Patients With Recurrent Prostate Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2010English

Prostate Cancer Derived Prostatic Acid Phosphatase Promotes an Osteoblastic Response in the Bone Microenvironment

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2013English

Prostatic Acid Phosphatase (ACPP; PAP)

Science-Business eXchange
2008English

Immunohistochemical Study of Prostatic Acid Phosphatase and Prostatic Specific Antigen in Prostatic Carcinoma

Japanese Journal of Urology
Urology
1987English

Vaccine Immunotherapy for Prostate Cancer

2012English

Novel Therapeutic Targets for Cancer Metastasis

Expert Review of Anticancer Therapy
OncologyPharmacology
2020English

Chemopreventive Target for Prostate Cancer: Prostatic Intraepithelial Neoplasia

2012English

Tyrosine Phosphorylation of C-ErbB-2 Is Regulated by the Cellular Form of Prostatic Acid Phosphatase in Human Prostate Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy